T1D Exchange’s cover photo
T1D Exchange

T1D Exchange

Hospitals and Health Care

Boston, MA 9,625 followers

T1D Exchange is a nonprofit dedicated to improving outcomes for the entire T1D population.

About us

T1D Exchange is a nonprofit organization that drives meaningful research and innovation in the treatment and prevention of type 1 diabetes (T1D). Through quality improvement and collaboration, we harness data and insights to advance T1D care, identify gaps in data and unmet needs in diabetes care, refine best practices and ultimately improve the care and quality of life of those living with T1D.

Industry
Hospitals and Health Care
Company size
11-50 employees
Headquarters
Boston, MA
Type
Nonprofit
Founded
2010
Specialties
Quality Improvement, Study Recruitment, Type 1 Diabetes, T1D, Diabetes, Custom Research, Outcomes Research, Clinic Collaborative, Real-World Evidence, Health Equity, Real-World Data, HEOR, RWE, RWD, Type 2 Diabetes, T2D, Online Registry, Patient Registry, Research Studies, and Population Health

Locations

Employees at T1D Exchange

Updates

  • Today at #ATTD2025: Here's where you can find work from our Quality Improvement Collaborative (T1DX-QI)! Join us for a short oral presentation this morning about diabetes technology usage in young adults, and another short oral presentation this afternoon about DKA and severe hypoglycemia in adults with T1D and CKD.

  • View organization page for T1D Exchange

    9,625 followers

    Meet Viral Shah, MD, a Professor of Medicine in the Division of Endocrinology and Metabolism and the Director of Diabetes Clinical Research at the Center for Diabetes and Metabolic Diseases at Indiana University School of Medicine. Dr. Shah also serves as the adult endocrinology PI at Indiana University for the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Dr. Shah has over 200 research publications in diabetes technology, therapeutics, and investigations of bone fragility and fracture prevention in adults with T1D. Most recently, Dr. Shah was the recipient of the 2024 Mary Tyler Moore and S. Robert Levine MD Excellence in Clinical Research Award from Breakthrough T1D. Learn more about Dr. Shah and his role in the T1DX-QI: https://t1dx.co/4bu33Ki

    • No alternative text description for this image
  • Helmsley’s Type 1 Diabetes Program is accepting concept notes through April 30th for projects exploring the role of innate immunity in the development of T1D.    Learn more and apply: https://lnkd.in/dR3k6bS4

    Helmsley is seeking proposals that evaluate and modulate innate immune cells in type 1 diabetes (T1D). If you are a biomedical researcher focused on interrogating innate immunity pathways, identifying biomarkers of disease progression or response to treatment, or developing therapies to prevent or delay T1D targeting innate immune cell pathways, we invite you to submit concept notes by April 30th, 2025! Learn more about our request for proposals and submission process here: https://lnkd.in/dR3k6bS4 #Type1Diabetes #T1D #InnateImmunity

    • No alternative text description for this image
  • Attending ATTD next week? Check out our presentation schedule below to find work from the T1D Exchange Quality Improvement Collaborative (T1DX-QI) at #ATTD2025. Want to schedule a meeting with us to discuss your custom research and study recruitment needs at ATTD? Let us know in our contact form: https://t1dx.co/3Dp6eX8 Thursday, March 20: - 10:05 a.m.: Young Adult Diabetes Technology Use in Pediatric and Adult Practices - 4:15 p.m.: Diabetic Ketoacidosis and Severe Hypoglycemia in Adults with Type 1 Diabetes and Chronic Kidney Disease: Data from T1D Exchange Real-World Observation Study Saturday, March 22: - 9:30 a.m.: Early Initiation Of Automated Insulin Delivery At Type 1 Diabetes Diagnosis In Children And Adolescents Is Associated With Improved Outcomes At Two Years Post Diagnosis. Poster presentation: - Healthcare Disparities in Adults with Type 1 Diabetes and Chronic Kidney Disease

    • No alternative text description for this image
  • View organization page for T1D Exchange

    9,625 followers

    We work with industry, academia, advocacy organizations, and other researchers to design, deploy, analyze, and report on various types of diabetes research. Our comprehensive diabetes data can uncover novel insights, turning information into practical, evidence-based solutions. We will guide you through the research process, from study design to deployment and research dissemination. Learn more about our research services: https://t1dx.co/4kJ7HYU

  • There are many unknowns about experiences with perimenopause and T1D, but one thing is certain: the hormone changes that come with perimenopause can wreak havoc on glucose levels. In a recent study of T1D Exchange Registry participants in perimenopause or menopause, we asked about the advice or knowledge they wish they’d had themselves before entering this transitional time of life. See some of what we’re learning about real experiences in perimenopause and be a part of the conversation! Read their experiences: https://t1dx.co/4bvLM3t

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
  • The T1D Exchange Research team collaborates with diabetes industry leaders to design studies to understand the preferences, experiences, and quality of life of people living with diabetes in our registry and online community. Read the latest updates on our work with Vertex Pharmaceuticals examining severe hypoglycemia's impact on sleep, productivity, and more among participants in the T1D Exchange Registry: https://t1dx.co/41DsZQ9

    • No alternative text description for this image
  • Our collaborative of more than 60 endocrinology clinics is fueled by some of the top leaders in diabetes care. Together, they identify gaps in care, develop and refine best practices, and share their research and learnings – driving improved diabetes care and outcomes for people with diabetes. Meet David T. Broome, MD, an Assistant Professor of Medicine in the Metabolism, Endocrinology, and Diabetes Division and a Caswell Diabetes Institute Clinical and Translational Research Scholar at the University of Michigan who leads several NIH- and industry-sponsored clinical trials, including using novel treatments to prevent the onset of type 1 diabetes. In this interview, Dr. Broome discusses his research, involvement with our Quality Improvement Collaborative, and hopes for the future of diabetes: https://t1dx.co/4k5jzUQ

    • No alternative text description for this image

Similar pages

Browse jobs